Drug Screening Market: Saliva, Urine & Blood Testing Demand & Insights

According to FutureWise analysis the market for drug screening in 2023 was US$ 7.3 billion, and is expected to reach US$ 24.43 billion by 2031 at a CAGR of 16.30%.

Drug screening involves assessing individuals for drug use, even if they do not show signs of intoxication or a substance use disorder. This screening can be conducted systematically or randomly among certain groups, including students, athletes, and individuals on probation. During the drug screening process, various samples—such as urine, blood, breath, saliva, sweat, or hair—may be tested.

Urine testing is the most commonly used method due to its non-invasive nature, speed, and ability to detect a wide range of drugs. It can identify drug use within 1 to 4 days, or even longer, depending on the drug. Blood testing is less common because it is invasive and can typically detect drugs only a few hours after use. Hair testing, although infrequent, can reveal drug use up to 100 days prior.

Government agencies enforce strict regulations that mandate alcohol and drug screening for safety reasons, alongside increasing efforts to monitor and address substance misuse. The rising global prevalence of substance misuse has led to a greater need for screening and a heightened demand for drug testing services. Additionally, the impacts of the COVID-19 pandemic—such as job losses, business closures, and economic downturns—have negatively affected mental health and contributed to increased rates of substance abuse. According to the CDC, 13.3% of Americans have either started using or increased their substance use in response to COVID-19-related anxiety or stress, leading to a significant rise in the demand for drug screening.

FutureWise Market Research has published a report that provides an insightful analysis of drug screening market trends that are affecting the overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=5775%20&type=requestsample

Drug Screening Market Segmentation:

By Product Type

• Analytical Instruments
• Immunoassay Analyzers
• Chromatography Instruments
• Breathalyzers
  • Fuel Cell Breathalyzers
  • Semiconductor Breathalyzers
  • Other Breathalyzers
• Rapid Testing Devices
  • Urine Testing Devices
    • Drug Testing Cups
    • DIP Cards
    • Drug Testing Cassettes
  • Oral Fluid Testing Devices
• Consumables
  • Assay Kits
  • Sample Collection Devices
  • Calibrators and Controls
  • Other Consumables

By Drug Screening Services

• Regulated
• Non-Regulated

By Sample Type

• Urine Samples
• Breath Samples
• Oral Fluid Samples
• Hair Samples
• Other Samples

By End-user

• Workplace
• Criminal Justice Systems and Law Enforcement Agencies
• Drug Treatment Centers
• Pain Management Centers
• Schools and Colleges
• Hospitals
• Individual Users
• Drug Testing Laboratories

By Region

• North America
• Latin America
• Europe
• Asia-Pacific
• Middle East and Africa

Competitive Landscape in Drug Screening Market:

• Abbott
• Dragerwerk
• Labcorp
• Quest Diagnostics
• Alfa Scientific Designs
• Lifeloc
• MPD Inc.
• Orasure
• Omega Laboratories
• Premier Biotech
• Psychemedics
• Roche
• Shimadzu
• Siemens Healthineers 
• Thermo Fisher Scientific

Buy Now the Latest Version of this Report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=5775&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Drug Screening Market By Product Type, By Drug Screening Services, By Sample Type, By End User and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.

• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com